Comparison of Two Titration Programs of Adding Insulin Detemir to Oral Antidiabetic Drugs in Poorly Controlled Type 2 Diabetes Patients.
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 15 Mar 2016 Planned End Date changed from 1 Nov 2015 to 1 May 2016 as reported by ClinicalTrials.gov record.
- 11 Oct 2012 Planned End Date changed from 1 Jun 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.